Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Uterine Cervical Neoplasms | 49 | 2024 | 2019 | 9.040 |
Why?
|
Papillomavirus Infections | 44 | 2024 | 1616 | 8.380 |
Why?
|
Papillomavirus Vaccines | 30 | 2024 | 496 | 7.980 |
Why?
|
Early Detection of Cancer | 30 | 2024 | 3198 | 2.800 |
Why?
|
Papillomaviridae | 11 | 2022 | 1120 | 2.350 |
Why?
|
Vaccination | 23 | 2024 | 3369 | 2.190 |
Why?
|
Cost-Benefit Analysis | 29 | 2024 | 5493 | 2.050 |
Why?
|
Norway | 19 | 2024 | 499 | 1.890 |
Why?
|
Human papillomavirus 18 | 7 | 2023 | 125 | 1.800 |
Why?
|
Human papillomavirus 16 | 9 | 2024 | 267 | 1.410 |
Why?
|
Colposcopy | 7 | 2023 | 149 | 1.220 |
Why?
|
Uterine Cervical Dysplasia | 6 | 2022 | 384 | 1.110 |
Why?
|
Mass Screening | 18 | 2024 | 5426 | 0.880 |
Why?
|
Vaginal Smears | 6 | 2024 | 499 | 0.840 |
Why?
|
Immunization Schedule | 2 | 2024 | 227 | 0.770 |
Why?
|
Quality-Adjusted Life Years | 12 | 2024 | 1723 | 0.730 |
Why?
|
Mass Vaccination | 2 | 2019 | 109 | 0.700 |
Why?
|
Cell Transformation, Viral | 1 | 2020 | 526 | 0.640 |
Why?
|
Self-Examination | 1 | 2016 | 71 | 0.540 |
Why?
|
Tumor Virus Infections | 1 | 2018 | 435 | 0.500 |
Why?
|
Models, Statistical | 7 | 2021 | 5081 | 0.480 |
Why?
|
Anus Neoplasms | 1 | 2018 | 330 | 0.470 |
Why?
|
Computer Simulation | 6 | 2024 | 6224 | 0.430 |
Why?
|
Incidence | 14 | 2024 | 21366 | 0.430 |
Why?
|
Female | 61 | 2024 | 392552 | 0.420 |
Why?
|
Urogenital Neoplasms | 1 | 2014 | 131 | 0.410 |
Why?
|
Health Care Costs | 6 | 2024 | 3239 | 0.380 |
Why?
|
Intention | 1 | 2014 | 347 | 0.370 |
Why?
|
Models, Economic | 5 | 2022 | 714 | 0.360 |
Why?
|
Models, Theoretical | 6 | 2024 | 3571 | 0.350 |
Why?
|
Developed Countries | 2 | 2024 | 448 | 0.330 |
Why?
|
Patient Compliance | 2 | 2017 | 2688 | 0.330 |
Why?
|
Cost of Illness | 1 | 2019 | 1936 | 0.330 |
Why?
|
Uncertainty | 4 | 2024 | 752 | 0.320 |
Why?
|
Adult | 35 | 2024 | 221120 | 0.320 |
Why?
|
Humans | 66 | 2024 | 761222 | 0.300 |
Why?
|
Healthcare Disparities | 4 | 2023 | 3354 | 0.280 |
Why?
|
Delivery of Health Care | 4 | 2023 | 5333 | 0.270 |
Why?
|
Patient Acceptance of Health Care | 4 | 2024 | 3200 | 0.260 |
Why?
|
Oropharyngeal Neoplasms | 2 | 2023 | 491 | 0.230 |
Why?
|
Alphapapillomavirus | 2 | 2018 | 218 | 0.220 |
Why?
|
Adolescent | 14 | 2024 | 88300 | 0.220 |
Why?
|
Age Factors | 4 | 2020 | 18384 | 0.210 |
Why?
|
Diabetic Retinopathy | 2 | 2022 | 1276 | 0.210 |
Why?
|
Middle Aged | 24 | 2024 | 220858 | 0.210 |
Why?
|
Age of Onset | 2 | 2020 | 3307 | 0.200 |
Why?
|
Advisory Committees | 2 | 2023 | 788 | 0.190 |
Why?
|
Sensitivity and Specificity | 4 | 2020 | 14675 | 0.190 |
Why?
|
Vaccines, Combined | 1 | 2021 | 70 | 0.190 |
Why?
|
Cervix Uteri | 2 | 2022 | 570 | 0.190 |
Why?
|
Young Adult | 13 | 2024 | 59222 | 0.180 |
Why?
|
Specimen Handling | 2 | 2024 | 702 | 0.180 |
Why?
|
Child | 11 | 2024 | 80154 | 0.170 |
Why?
|
Models, Biological | 5 | 2020 | 9458 | 0.170 |
Why?
|
Life Expectancy | 2 | 2024 | 1242 | 0.170 |
Why?
|
Waiting Lists | 1 | 2024 | 766 | 0.160 |
Why?
|
Cytological Techniques | 1 | 2021 | 218 | 0.160 |
Why?
|
Anxiety | 1 | 2014 | 4569 | 0.160 |
Why?
|
Decision Trees | 2 | 2024 | 505 | 0.160 |
Why?
|
Triage | 2 | 2023 | 985 | 0.160 |
Why?
|
Neoplasms | 2 | 2019 | 22142 | 0.160 |
Why?
|
Time | 1 | 2020 | 545 | 0.150 |
Why?
|
Geography | 1 | 2020 | 652 | 0.150 |
Why?
|
Policy | 1 | 2022 | 506 | 0.150 |
Why?
|
Macular Edema | 1 | 2022 | 374 | 0.150 |
Why?
|
Algorithms | 2 | 2017 | 14025 | 0.140 |
Why?
|
Sweden | 1 | 2020 | 1379 | 0.140 |
Why?
|
Uganda | 2 | 2019 | 1332 | 0.140 |
Why?
|
Immunity, Herd | 1 | 2016 | 46 | 0.130 |
Why?
|
Health Policy | 2 | 2019 | 2679 | 0.130 |
Why?
|
Calibration | 1 | 2018 | 819 | 0.130 |
Why?
|
Developing Countries | 4 | 2020 | 2863 | 0.130 |
Why?
|
Cancer Vaccines | 1 | 2023 | 1038 | 0.120 |
Why?
|
Natural Orifice Endoscopic Surgery | 1 | 2016 | 119 | 0.120 |
Why?
|
Hysterectomy | 1 | 2020 | 857 | 0.120 |
Why?
|
Monte Carlo Method | 3 | 2015 | 1256 | 0.120 |
Why?
|
Genotype | 2 | 2020 | 12985 | 0.120 |
Why?
|
Epidemics | 1 | 2020 | 512 | 0.110 |
Why?
|
Diabetes, Gestational | 1 | 2024 | 1250 | 0.110 |
Why?
|
United States | 10 | 2023 | 72341 | 0.110 |
Why?
|
Diabetes Mellitus | 2 | 2022 | 5842 | 0.110 |
Why?
|
Risk Reduction Behavior | 1 | 2020 | 1111 | 0.110 |
Why?
|
Practice Guidelines as Topic | 4 | 2018 | 7400 | 0.110 |
Why?
|
Cause of Death | 1 | 2024 | 3688 | 0.110 |
Why?
|
Radiotherapy, Conformal | 1 | 2016 | 548 | 0.110 |
Why?
|
Aged | 14 | 2024 | 169292 | 0.110 |
Why?
|
False Negative Reactions | 1 | 2014 | 573 | 0.100 |
Why?
|
Liver Transplantation | 1 | 2024 | 2332 | 0.100 |
Why?
|
CD4 Lymphocyte Count | 1 | 2018 | 2570 | 0.100 |
Why?
|
Terminal Care | 1 | 2024 | 1760 | 0.100 |
Why?
|
Health Status Disparities | 1 | 2023 | 1847 | 0.100 |
Why?
|
HIV Infections | 1 | 2018 | 17348 | 0.100 |
Why?
|
Age Distribution | 1 | 2017 | 2871 | 0.100 |
Why?
|
School Health Services | 1 | 2015 | 384 | 0.100 |
Why?
|
Guidelines as Topic | 1 | 2018 | 1385 | 0.090 |
Why?
|
Colorectal Neoplasms | 2 | 2024 | 6919 | 0.090 |
Why?
|
Health Services Needs and Demand | 1 | 2019 | 1401 | 0.090 |
Why?
|
Forecasting | 1 | 2020 | 2928 | 0.090 |
Why?
|
Male | 15 | 2024 | 360703 | 0.090 |
Why?
|
Intravitreal Injections | 2 | 2022 | 385 | 0.090 |
Why?
|
Precancerous Conditions | 1 | 2017 | 982 | 0.090 |
Why?
|
Pandemics | 2 | 2021 | 8663 | 0.090 |
Why?
|
DNA, Viral | 1 | 2017 | 2195 | 0.090 |
Why?
|
Quality Improvement | 2 | 2016 | 3808 | 0.090 |
Why?
|
Liver Neoplasms | 1 | 2024 | 4310 | 0.080 |
Why?
|
Decision Support Techniques | 1 | 2018 | 2004 | 0.080 |
Why?
|
Program Evaluation | 1 | 2016 | 2489 | 0.070 |
Why?
|
Income | 3 | 2020 | 1869 | 0.070 |
Why?
|
New Mexico | 2 | 2018 | 83 | 0.070 |
Why?
|
Time Factors | 5 | 2018 | 39957 | 0.060 |
Why?
|
Biopsy | 1 | 2017 | 6781 | 0.060 |
Why?
|
Risk | 1 | 2017 | 9616 | 0.060 |
Why?
|
Pregnancy | 2 | 2024 | 29893 | 0.060 |
Why?
|
Data Collection | 1 | 2014 | 3320 | 0.060 |
Why?
|
Referral and Consultation | 1 | 2017 | 3608 | 0.060 |
Why?
|
Prevalence | 2 | 2018 | 15721 | 0.060 |
Why?
|
Disease Progression | 1 | 2020 | 13511 | 0.050 |
Why?
|
Pilot Projects | 1 | 2016 | 8642 | 0.050 |
Why?
|
Quality of Life | 2 | 2021 | 13367 | 0.050 |
Why?
|
Anti-HIV Agents | 1 | 2018 | 4527 | 0.050 |
Why?
|
Registries | 4 | 2024 | 8246 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3093 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2020 | 20118 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3215 | 0.050 |
Why?
|
Parents | 1 | 2015 | 3564 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2016 | 4021 | 0.050 |
Why?
|
Logistic Models | 1 | 2014 | 13249 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39127 | 0.040 |
Why?
|
Lasers | 1 | 2022 | 952 | 0.040 |
Why?
|
Home Care Services | 1 | 2024 | 647 | 0.040 |
Why?
|
Occult Blood | 1 | 2017 | 197 | 0.030 |
Why?
|
Risk Factors | 3 | 2018 | 74241 | 0.030 |
Why?
|
Infant | 3 | 2024 | 36170 | 0.030 |
Why?
|
Evaluation Studies as Topic | 1 | 2017 | 1624 | 0.030 |
Why?
|
SEER Program | 1 | 2020 | 1453 | 0.030 |
Why?
|
Models, Econometric | 1 | 2015 | 215 | 0.030 |
Why?
|
Oral Surgical Procedures | 1 | 2016 | 165 | 0.030 |
Why?
|
Measles-Mumps-Rubella Vaccine | 1 | 2015 | 71 | 0.030 |
Why?
|
Dexamethasone | 1 | 2022 | 1945 | 0.030 |
Why?
|
California | 1 | 2018 | 1431 | 0.030 |
Why?
|
World Health Organization | 1 | 2020 | 1321 | 0.030 |
Why?
|
Immunization Programs | 1 | 2015 | 267 | 0.030 |
Why?
|
Radiotherapy | 1 | 2019 | 1500 | 0.030 |
Why?
|
Angiogenesis Inhibitors | 1 | 2022 | 2047 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2023 | 3691 | 0.020 |
Why?
|
Internationality | 1 | 2016 | 999 | 0.020 |
Why?
|
Feces | 1 | 2017 | 1490 | 0.020 |
Why?
|
Costs and Cost Analysis | 1 | 2016 | 1664 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2024 | 7804 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2017 | 20982 | 0.020 |
Why?
|
Decision Making | 1 | 2023 | 3931 | 0.020 |
Why?
|
Health Expenditures | 1 | 2022 | 2362 | 0.020 |
Why?
|
Hospitals | 1 | 2022 | 3881 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5250 | 0.020 |
Why?
|
Mortality | 1 | 2020 | 2896 | 0.020 |
Why?
|
Poverty | 1 | 2019 | 2691 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2024 | 58952 | 0.020 |
Why?
|
Mammography | 1 | 2017 | 2430 | 0.020 |
Why?
|
Social Class | 1 | 2015 | 1993 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2015 | 2220 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2021 | 5426 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2019 | 64681 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2018 | 15308 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2017 | 14610 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2024 | 12159 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2020 | 26200 | 0.010 |
Why?
|
Child, Preschool | 1 | 2020 | 42225 | 0.010 |
Why?
|
Concepts
(167)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(6)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_